UPDATE: Cantor Fitzgerald Starts Sorrento Therapeutics (SRNE) at Overweight
Tweet Send to a Friend
(Updated - November 2, 2022 6:41 AM EDT)
Cantor Fitzgerald analyst Brandon Folkes initiates coverage on Sorrento Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cantor Fitzgerald analyst Brandon Folkes initiates coverage on Sorrento Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
